The new OncoAlert 🚨 newsletter is OUT!
Don’t miss it! And if you don’t have a subscription, register at oncoalert.m-pages.com/nhMpwe/oncoale… for the latest in oncology.

Just out on Journal for ImmunoTherapy of Cancer 🚨
The Society for Immunotherapy🧪 of Cancer's expert panel devised tailored clinical trial designs to maximize the efficacy of intratumoral immunotherapies across various stages of #Cancer

✅addressing key considerations such as patient selection,…

Gefitinib + chemotherapy combo continues to show ⬆️PFS & OS at 5y of follow-up vs gefitinib monotherapy in #EGFR + #NSCLC .
5-year OS: 13% vs 4.4% (HR, 0.58). 5-year PFS: 6.7% vs 1.7% (HR, 0.53). Implications for countries with limited access to 3rd gen TKIs 🚨🚨OncoAlert #LCSM

Dear Colleagues,
One Month until #ASCO24 🌐
WE ARE READY
WE ARE OncoAlert 🚨

#OncoAlertAF
Dra. María Natalia Gandur Quiroga 🇦🇷
Alizée Camps - - Maléa 🇫🇷
Marta Perachino 🇮🇹
Kathrin Heinrich 🇩🇪
Biagio Ricciuti, MD PhD 🇺🇸
Deniz Can Guven 🇹🇷
Emre Yekedüz 🇺🇸
Hidehito HORINOUCHI 🇯🇵
Fadi Haddad, MD 🇺🇸
Dr. Iván R. González 🇲🇽…

If you are attending #ASCO24 don’t forget to register to the 🚨 OncoAlert 5K walk/run. June 1st, 7 AM. Start Hyatt Regency at McCormick Place, Chicago!
⬇️⬇️⬇️

Dear Colleagues
Grab your morning coffee☕️Get comfortable and get ready to have some FUN with GU Cast | Urology podcast! , Uromigos and OncoAlert 🚨as we have some amazing conversation right next to Lake Lugano at #APCCC24 🇨🇭

We Love this Lot and dont forget to follow:
Declan Murphy🇦🇺…

AN AMAZING TWEETORIAL
SUM Up of FIRST DAY OF #APCCC24 🇨🇭
Author: #OncoAlertAF Dra. María Natalia Gandur Quiroga 🇦🇷

Pinging OncoAlert 🚨GU faculty
Sumanta K. Pal, MD, FASCO Cristiane D Bergerot Daniel Heng Andrea Apolo, M.D. Toni Choueiri, MD Petros Grivas Tian Zhang, MD, MHS Hans Hammers Ravindran Kanesvaran Neeraj Agarwal, MD, FASCO Axel S. Merseburger…

Somethings a Brewin here in Lugano🇨🇭
Live from #APCCC24
Uromigos GU Cast | Urology podcast! OncoAlert 🚨
WEBCAST...Coming Soon‼️

Declan Murphy 🇦🇺
Renu Eapen 🇦🇺
Brian Rini, MD 🇺🇸
Tom Powles 🇬🇧
Gil Morgan, MD 🇺🇸

Sumanta K. Pal, MD, FASCO Cristiane D Bergerot Daniel Heng Andrea Apolo, M.D. Toni Choueiri, MD Petros Grivas…

In a new study published in JTO & JTO CRR IASLC, Biagio Ricciuti, MD PhD and @danafarber researchers showed improved long-term survival with pembrolizumab & cemiplimab in NSCLC patients with PD-L1 >90% vs 50-89%. #LCSM
Read more here: ms.spr.ly/6010YyynQ

Check out the new OncoAlert newsletter (April 19-24, 2024). Thank you Gil Morgan, MD for keeping the community updated!!

Important case study by💫Renato Umeton, Ph.D. et al. in NEJM AI reporting on the challenges and lessons learned in the deployment of large language models (LLMs) at Dana-Farber for use in basic research, clinical research, operations, & more! OncoAlert
ai.nejm.org/doi/full/10.10…

📢 OncoAlert newsletter out !!
Don’t miss it ! ☢️
#OncoAlertAF

JUST 2⃣DAYS AWAY
OncoAlert 🚨 is Proud to be collaborating w/ our friends at Advanced Prostate Cancer Consensus Conference & our AMAZING #APCCC24 Faculty
FREE VIRTUAL REGISTRATION FOR SOME LMICs
Register Here onlineevent.ch/APCCC/2024

Gil Morgan, MD 🇺🇸with a warm invitation to this very important…

Dear Colleagues
OncoAlert & the #OncoAlertAF 🚨 are ready for #ASCO24 with many initiatives coming for Chicago Warm recommendation to follow our #AF

Emre Yekedüz 🇺🇸
Elisa Agostinetto 🇮🇹
Hidehito HORINOUCHI 🇯🇵
Elisabetta Bonzano 🇮🇹
Fadi Haddad, MD 🇺🇸
Dr. Iván R. González 🇲🇽
Biagio Ricciuti, MD PhD…

Pooled 5y outcomes of Pembro+Chemo vs Chemo for PDL1<1% metastatic #NSCLC (KN189, KN407 + Japan/China extensions).

OS HR: 0.64, PFS HR: 0.66 & 5y OS 12.5% vs 9.3% favoring Pembro+Chemo.
JTO & JTO CRR IASLC Shirish Gadgeel Marina Garassino OncoAlert 🚨

jto.org/article/S1556-…

In metastatic non-small cell lung cancer treated w/ First-line pembrolizumab 🧪and cemiplimab

✅ PD-L1 expression ≥9⃣0⃣%, had significant3⃣year survival benefits 🆚 those with PD-L1 expression levels of 50-89%

Highlighting the potential for personalized treatment approaches…

THE OncoAlert 🚨5K REGISTRATION at #ASCO24 Saturday, June 1st at 7am (Chicago)
Start Hyatt Regency at McCormick Place
Countries participating: 🇺🇸🇮🇹🇧🇪🇦🇹🇨🇭🇲🇽🇹🇷🇫🇷🇸🇪

oncoalert.m-pages.com/T8RKPR/the-onc…

#OncoAlertAF
Dra. María Natalia Gandur Quiroga Alizée Camps - - Maléa Marta Perachino Kathrin Heinrich Biagio Ricciuti, MD PhD…